In breast cancer, the regulatory effect of CITED2 on CCL20 has been reported by Jayaraman et al. According to the authors, silencing CITED2 in MDA-MB-231 cell line attenuates the recruitment of macrophages mediated by CCL20 [57]. Here, CCL20 is linked to breast cancer.